跳至主要内容
临床试验/IRCT20230619058530N2
IRCT20230619058530N2招募中3 期

Randomized Clinical Trial, effects of combination treatment with Tizanidine and long-acting Stimulants in ADHD.

Esfahan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
9 years 至 18 years(—)
性别
All

入选标准

  • Clinical diagnosis of Attention Deficit Hyperactivity Disorder according to DSM-5 criteria
  • completing the informed consent form by parent and patient
  • negative history for any chronic medical diseases
  • negative history for drug induced allergy
  • negative history of receiving any Anti hypertensive, Alpha blockers or Beta blockers during recent three months before study
  • Lack of history of any comorbid psychiatric disorder

排除标准

  • Any unexpected physical or mental condition that effects on treatment regimen
  • unwillingness of patients or parents to continue study procedure

研究者

相似试验